Is There an Allergy to Pure Metallic Gold Microparticles?
Primary Purpose
Allergic Reaction
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Gold microparticles
Gold thiosulphate
Sponsored by
About this trial
This is an interventional diagnostic trial for Allergic Reaction
Eligibility Criteria
Inclusion Criteria:
- Patients with chronic dermatitis
Exclusion Criteria:
- age < 18
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Gold microparticles
Gold thiosulphate
Arm Description
Metallic gold microparticles, 20-micron diameter, 1 % w/v in petrolatum
Gold Sodium Thio Sulphate, 1 % w/v in petrolatum
Outcomes
Primary Outcome Measures
Patch test
Test materials will be applied on the upper back of the volunteers in aluminium Finn Chambers for 48 hours. Clinical evaluation will be performed 24 hours after removal of the test substances according to standard procedures for evaluation of epicutaneous challenging according to criteria of ICDRG (International Contact Dermatitis Research Group) (Johansen 2015)
Secondary Outcome Measures
Full Information
NCT ID
NCT05284253
First Posted
November 21, 2021
Last Updated
March 16, 2022
Sponsor
Northern Orthopaedic Division, Denmark
Collaborators
Aalborg University
1. Study Identification
Unique Protocol Identification Number
NCT05284253
Brief Title
Is There an Allergy to Pure Metallic Gold Microparticles?
Official Title
Is There an Allergy to Pure Metallic Gold Microparticles?: A Epicutaneous Test of Gold Microparticles, Gold Thiosulphate and Placebo.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
June 1, 2022 (Anticipated)
Primary Completion Date
August 31, 2022 (Anticipated)
Study Completion Date
October 30, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Northern Orthopaedic Division, Denmark
Collaborators
Aalborg University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators hypothesize gold is inert and thereby there is no pure-gold allergy. The primary aim of this study is to measure the prevalence of allergy to metallic pure gold microparticles and allergy to GSTS.
Detailed Description
TRUE test panel which includes gold sodium thiosulphate (GSTS), 1 % w/v in petrolatum, and gold microparticles, 20-micron diameter, 1 % w/v in petrolatum, will be added added to the baseline series. It will be applied to the upper back of healthy adults in aluminum Finn Chamber for 48 hours. Clinical evaluation will be performed 24 hours after removal the test according to standard procedures for evaluation of epi-cutaneous challenging (Johansen 2015).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Allergic Reaction
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Non-Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Gold microparticles
Arm Type
Experimental
Arm Description
Metallic gold microparticles, 20-micron diameter, 1 % w/v in petrolatum
Arm Title
Gold thiosulphate
Arm Type
Active Comparator
Arm Description
Gold Sodium Thio Sulphate, 1 % w/v in petrolatum
Intervention Type
Other
Intervention Name(s)
Gold microparticles
Other Intervention Name(s)
Patch test
Intervention Description
Metallic gold microparticles, 20-micron diameter, 1 % w/v in petrolatum
Intervention Type
Other
Intervention Name(s)
Gold thiosulphate
Other Intervention Name(s)
Patch test
Intervention Description
Gold Sodium Thio Sulphate, 1 % w/v in petrolatum
Primary Outcome Measure Information:
Title
Patch test
Description
Test materials will be applied on the upper back of the volunteers in aluminium Finn Chambers for 48 hours. Clinical evaluation will be performed 24 hours after removal of the test substances according to standard procedures for evaluation of epicutaneous challenging according to criteria of ICDRG (International Contact Dermatitis Research Group) (Johansen 2015)
Time Frame
72 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with chronic dermatitis
Exclusion Criteria:
age < 18
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sten Rasmussen, PhD
Phone
25520462
Email
sten@dcm.aau.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sten Rasmussen, PhD
Organizational Affiliation
Department of Clinical Medicine, Aalborg Unviversity
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Is There an Allergy to Pure Metallic Gold Microparticles?
We'll reach out to this number within 24 hrs